Fact Sheet/Brochure

SAMHSA recognizes the challenges posed by the current COVID-19 situation and is providing the following guidance on the provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency for Opioid Treatment Programs.

Looks at various barriers to accessing mental health and substance use disorder treatment and services in rural communities and describes how telehealth interventions may provide ways to overcome specific barriers

Provides an overview of Federal confidentiality laws as they pertain to SBIRT

Assists providers in determining whether their SBIRT services are protected by Federal confidentiality laws, 42 CFR Part 2

Patient handout defining a standard drink and giving reasons patients should consider drinking less

Educational poster in Spanish for display in patient exam room about why providers ask everyone about alcohol use

Educational poster for display in patient exam room about why providers ask everyone about alcohol use

Poster for primary care settings to help normalize asking about alcohol and substance use during the visit

Provides an overview of alcohol overdose signs and symptoms and when to seek medical help

Educational poster for display in medical settings to educate Spanish-speaking patients about lower risk drink limits